Healthcare Services · Key players

Top Bone Cancer Diagnostic companies

The 10 key players our Bone Cancer Diagnostic report profiles, and other companies free public records show in this market.

Key players in Bone Cancer Diagnostic

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Bone Cancer Diagnostic market
#CompanyWebsiteOur reports
1 GE Healthcare gehealthcare.com (opens in a new tab) 1,254 reports
2 Roche Diagnostics roche-diagnostics.ch (opens in a new tab) 924 reports
3 BD (Becton, Dickinson) bd.com (opens in a new tab) 759 reports
4 Philips Healthcare philips.com (opens in a new tab) 1,419 reports
5 Siemens Healthineers siemens-healthineers.com (opens in a new tab) 1,155 reports
6 Abbott Laboratories — 2,310 reports
7 Roche roche.com (opens in a new tab) 1,485 reports
8 Merck & Co., Inc. merck.com (opens in a new tab) 1,320 reports
9 Johnson & Johnson jnj.com (opens in a new tab) 2,376 reports
10 Amgen Inc. amgen.com (opens in a new tab) 693 reports

Also active in Bone Cancer Diagnostic

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Bone Cancer Diagnostic, from free public records
CompanyWhere public records show them
Novartis AG
Incyte
Shenzhen TargetRx Co., Ltd.
PharmaEssentia Corporation
Takeda Pharmaceutical Company Ltd
Bellicum Pharmaceuticals
AbbVie Inc.
Orca Biosystems, Inc.
Ossium Health, Inc.
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Enliven Therapeutics
Taiho Oncology, Inc.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Bone Cancer Diagnostic

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Novartis AG 18 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Incyte 7 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Shenzhen TargetRx Co., Ltd. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  4. PharmaEssentia Corporation 5 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Takeda Pharmaceutical Company Ltd 4 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Bellicum Pharmaceuticals 4 active trials on ClinicalTrials.gov (opens in a new tab)
  7. AbbVie Inc. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Orca Biosystems, Inc. 4 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Bone Cancer Diagnostic reports by place

All 33 places for Bone Cancer Diagnostic

Get the full Bone Cancer Diagnostic report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.